BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Large Drop in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a large decline in short interest in December. As of December 15th, there was short interest totaling 1,083 shares, a decline of 63.8% from the November 30th total of 2,988 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 9,969 shares, the days-to-cover ratio is presently 0.1 days. Based on an average trading volume of 9,969 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.

BioNxt Solutions Price Performance

BNXTF stock opened at $0.45 on Friday. The business has a fifty day moving average price of $0.51 and a 200 day moving average price of $0.54. BioNxt Solutions has a fifty-two week low of $0.21 and a fifty-two week high of $0.80. The stock has a market capitalization of $52.43 million, a price-to-earnings ratio of -11.32 and a beta of 0.82.

BioNxt Solutions (OTCMKTS:BNXTF) last posted its quarterly earnings data on Friday, November 28th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.01 million during the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.